B. Gumbiner et al., DIFFERENTIAL-EFFECTS OF ACUTE HYPERTRIGLYCERIDEMIA ON INSULIN ACTION AND INSULIN-RECEPTOR AUTOPHOSPHORYLATION, American journal of physiology: endocrinology and metabolism, 33(3), 1996, pp. 424-429
Experimentally induced hypertriglyceridemia (HTG) and high plasma free
fatty acid (FFA) levels impair in vivo insulin action. To determine i
f this is a consequence of impaired in vive insulin receptor autophosp
horylation and related to defective receptor signaling, hyperinsulinem
ic euglycemic clamps, indirect calorimetry, and skeletal muscle biopsi
es were performed in nine healthy subjects. In vive insulin action was
determined from the glucose infusion rate (GINF) and glucose oxidatio
n (Glc(ox)) during 40 and 120 mU . m(-2). min(-1) clamps with (HTG cla
mp) and without (control clamp) a triglyceride emulsion infusion. The
percentage of receptors autophosphorylated in vivo was determined by I
-125-labeled insulin tracer binding in skeletal muscle immunoprecipita
tes of insulin receptors and phosphorylated receptors. Compared with t
he control clamps, plasma triglycerides and FFA increased four- and tw
ofold, whereas GINF and Glc(ox) decreased 15 and 35%, respectively, du
ring the HTG clamps (all P < 0.05). However, the percentages of recept
ors phosphorylated after the 40 and 120 mU . m(-2). min(-1) HTG clamps
(9.2 +/- 1.5 and 21.1 +/- 2.6%, respectively) were similar to the con
trol clamps (9.0 +/- 0.6 and 18.6 +/- 2.2%, respectively). These resul
ts indicate that, if impaired insulin signal transduction is a mechani
sm by which HTG and FFA impair insulin action, it occurs at a site dow
nstream from insulin receptor autophosphorylation.